{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:13:49Z","timestamp":1787004829329,"version":"build-2736575974"},"reference-count":67,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100016947","name":"Swim Across America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019310","name":"Northwell Health Feinstein Institutes for Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019310","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1053\/j.seminhematol.2024.03.003","type":"journal-article","created":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T04:05:34Z","timestamp":1712808334000},"page":"201-207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Mouse models of CLL: In vivo modeling of disease initiation, progression, and transformation"],"prefix":"10.1053","volume":"61","author":[{"given":"Shih-Shih","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1053\/j.seminhematol.2024.03.003_bib0001","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a035220","article-title":"Chronic lymphocytic leukemia","volume":"11","author":"Chiorazzi","year":"2021","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"6","key":"10.1053\/j.seminhematol.2024.03.003_bib0002","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/leu.2017.11","article-title":"Direct in vivo evidence for increased proliferation of CLL cells in lymph nodes compared to bone marrow and peripheral blood","volume":"31","author":"Herndon","year":"2017","journal-title":"Leukemia"},{"issue":"12","key":"10.1053\/j.seminhematol.2024.03.003_bib0003","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1158\/2159-8290.CD-21-0276","article-title":"Longitudinal single-cell dynamics of chromatin accessibility and mitochondrial mutations in chronic lymphocytic leukemia mirror disease history","volume":"11","author":"Penter","year":"2021","journal-title":"Cancer Discov"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.03.003_bib0004","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1158\/2643-3230.BCD-19-0058","article-title":"Preneoplastic alterations define CLL DNA methylome and persist through disease progression and therapy","volume":"2","author":"Kretzmer","year":"2021","journal-title":"Blood Cancer Discov"},{"issue":"11","key":"10.1053\/j.seminhematol.2024.03.003_bib0005","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1038\/s41588-022-01140-w","article-title":"Molecular map of chronic lymphocytic leukemia and its impact on outcome","volume":"54","author":"Knisbacher","year":"2022","journal-title":"Nat Genet"},{"issue":"9","key":"10.1053\/j.seminhematol.2024.03.003_bib0006","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1158\/2159-8290.CD-14-0104","article-title":"Acquired initiating mutations in early ematopoietic cells of CLL patients","volume":"4","author":"Damm","year":"2014","journal-title":"Cancer Discov"},{"key":"10.1053\/j.seminhematol.2024.03.003_bib0007","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13045-017-0450-y","article-title":"Next-generation sequencing and FISH studies reveal the appearance of gene mutations and chromosomal abnormalities in hematopoietic progenitors in chronic lymphocytic leukemia","volume":"10","author":"Quijada-\u00c1lamo","year":"2017","journal-title":"J Hematol Oncol"},{"issue":"4","key":"10.1053\/j.seminhematol.2024.03.003_bib0008","first-page":"1041","article-title":"Somatic CLL mutations occur at multiple distinct hematopoietic maturation stages: documentation and cautionary note regarding cell fraction purity","volume":"32","author":"Marsilio","year":"2017","journal-title":"Leukemia"},{"issue":"8","key":"10.1053\/j.seminhematol.2024.03.003_bib0009","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1101\/gr.217331.116","article-title":"Integrated single-cell genetic and transcriptional analysis suggests novel drivers of chronic lymphocytic leukemia","volume":"27","author":"Wang","year":"2017","journal-title":"Genome Res"},{"issue":"4","key":"10.1053\/j.seminhematol.2024.03.003_bib0010","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.cell.2013.01.019","article-title":"Evolution and impact of subclonal mutations in chronic lymphocytic leukemia","volume":"152","author":"Landau Dan","year":"2013","journal-title":"Cell"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.03.003_bib0011","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1182\/bloodadvances.2021006941","article-title":"The immune microenvironment shapes transcriptional and genetic heterogeneity in chronic lymphocytic leukemia","volume":"7","author":"Sun","year":"2023","journal-title":"Blood Adv"},{"issue":"20","key":"10.1053\/j.seminhematol.2024.03.003_bib0012","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1182\/blood.2020005650","article-title":"Genomic and transcriptomic correlates of Richter transformation in chronic lymphocytic leukemia","volume":"137","author":"Klintman","year":"2021","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.03.003_bib0013","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41591-022-02113-6","article-title":"Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome","volume":"29","author":"Parry","year":"2023","journal-title":"Nat Med"},{"issue":"8","key":"10.1053\/j.seminhematol.2024.03.003_bib0014","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1038\/s41591-022-01927-8","article-title":"Detection of early seeding of Richter transformation in chronic lymphocytic leukemia","volume":"28","author":"Nadeu","year":"2022","journal-title":"Nat Med"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.03.003_bib0015","first-page":"11","article-title":"Richter syndrome: novel insights into the biology of transformation","volume":"142","author":"Parry","year":"2023","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.03.003_bib0016","doi-asserted-by":"crossref","first-page":"824","DOI":"10.3324\/haematol.2022.282542","article-title":"Autonomous B-cell receptor signaling and genetic aberrations in chronic lymphocytic leukemia-phenotype monoclonal B lymphocytosis in siblings of patients with chronic lymphocytic leukemia","volume":"109","author":"Quinten","year":"2024","journal-title":"Haematologica"},{"issue":"5","key":"10.1053\/j.seminhematol.2024.03.003_bib0017","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/leu.2015.351","article-title":"Next-generation IgVH sequencing CLL-like monoclonal B-cell lymphocytosis reveals frequent oligoclonality and ongoing hypermutation","volume":"30","author":"Klinger","year":"2016","journal-title":"Leukemia"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.03.003_bib0018","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1158\/2159-8290.CD-21-0276","article-title":"Longitudinal single-cell dynamics of chromatin accessibility and mitochondrial mutations in chronic lymphocytic leukemia mirror disease history","volume":"11","author":"Penter","year":"2021","journal-title":"Cancer Discov"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.03.003_bib0019","first-page":"11","article-title":"Richter syndrome: novel insights into the biology of transformation","volume":"142","author":"Parry","year":"2023","journal-title":"Blood"},{"issue":"25","key":"10.1053\/j.seminhematol.2024.03.003_bib0020","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1182\/blood.2021011993","article-title":"Understanding CLL biology through mouse models of human genetics","volume":"138","author":"Ten Hacken","year":"2021","journal-title":"Blood"},{"issue":"2","key":"10.1053\/j.seminhematol.2024.03.003_bib0021","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1053\/j.seminoncol.2016.02.007","article-title":"Preclinical modeling of novel therapeutics in chronic lymphocytic leukemia: the tools of the trade","volume":"43","author":"Herman","year":"2016","journal-title":"Semin Oncol"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.03.003_bib0022","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1053\/j.seminhematol.2014.05.001","article-title":"Murine genetically engineered and human xenograft models of chronic lymphocytic leukemia","volume":"51","author":"Chen","year":"2014","journal-title":"Semin Hematol"},{"issue":"4","key":"10.1053\/j.seminhematol.2024.03.003_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2023.102165","article-title":"Generation of mouse models carrying B cell restricted single or multiplexed loss-of-function mutations through CRISPR-Cas9 gene editing","volume":"4","author":"Ten Hacken","year":"2023","journal-title":"STAR Protoc"},{"key":"10.1053\/j.seminhematol.2024.03.003_bib0024","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3389\/fonc.2018.00105","article-title":"NOTCH1 is aberrantly activated in chronic lymphocytic leukemia hematopoietic stem cells","volume":"8","author":"Di Ianni","year":"2018","journal-title":"Front Oncol"},{"issue":"5","key":"10.1053\/j.seminhematol.2024.03.003_bib0025","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3324\/haematol.2017.177212","article-title":"Highly similar genomic landscapes in monoclonal B-cell lymphocytosis and ultra-stable chronic lymphocytic leukemia with low frequency of driver mutations","volume":"103","author":"Agathangelidis","year":"2018","journal-title":"Haematologica"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.03.003_bib0026","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/leu.2016.172","article-title":"Genomic characterization of high-count MBL cases indicates that early detection of driver mutations and subclonal expansion are predictors of adverse clinical outcome","volume":"31","author":"Barrio","year":"2017","journal-title":"Leukemia"},{"issue":"5","key":"10.1053\/j.seminhematol.2024.03.003_bib0027","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/leu.2015.351","article-title":"Next-generation IgVH sequencing CLL-like monoclonal B-cell lymphocytosis reveals frequent oligoclonality and ongoing hypermutation","volume":"30","author":"Klinger","year":"2016","journal-title":"Leukemia"},{"issue":"7574","key":"10.1053\/j.seminhematol.2024.03.003_bib0028","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nature15395","article-title":"Mutations driving CLL and their evolution in progression and relapse","volume":"526","author":"Landau","year":"2015","journal-title":"Nature"},{"issue":"7574","key":"10.1053\/j.seminhematol.2024.03.003_bib0029","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature14666","article-title":"Non-coding recurrent mutations in chronic lymphocytic leukaemia","volume":"526","author":"Puente","year":"2015","journal-title":"Nature"},{"issue":"7762","key":"10.1053\/j.seminhematol.2024.03.003_bib0030","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41586-019-1252-x","article-title":"Growth dynamics in naturally progressing chronic lymphocytic leukaemia","volume":"570","author":"Gruber","year":"2019","journal-title":"Nature"},{"issue":"2","key":"10.1053\/j.seminhematol.2024.03.003_bib0031","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ccr.2011.06.029","article-title":"Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia","volume":"20","author":"Kikushige","year":"2011","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.03.003_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111115","article-title":"Leukemia-initiating HSCs in chronic lymphocytic leukemia reveal clonal leukemogenesis and differential drug sensitivity","volume":"40","author":"Chiang","year":"2022","journal-title":"Cell Rep"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.03.003_bib0033","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ccr.2009.11.019","article-title":"The DLEU2\/miR-15a\/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia","volume":"17","author":"Klein","year":"2010","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.03.003_bib0034","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ccell.2021.02.003","article-title":"A hotspot mutation in transcription factor IKZF3 drives B cell neoplasia via transcriptional dysregulation","volume":"39","author":"Lazarian","year":"2021","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1053\/j.seminhematol.2024.03.003_bib0035","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ccell.2018.12.013","article-title":"A murine model of chronic lymphocytic leukemia based on B cell-restricted expression of Sf3b1 mutation and Atm deletion","volume":"35","author":"Yin","year":"2019","journal-title":"Cancer Cell"},{"issue":"17","key":"10.1053\/j.seminhematol.2024.03.003_bib0036","doi-asserted-by":"crossref","DOI":"10.1172\/JCI163325","article-title":"SF3B1 mutation and ATM deletion co-drive leukemogenesis via centromeric R-loop dysregulation","volume":"133","author":"Cusan","year":"2023","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.03.003_bib0037","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/s41467-023-36452-w","article-title":"A versatile, high-efficiency platform for CRISPR-based gene activation","volume":"14","author":"Heidersbach","year":"2023","journal-title":"Nat Commun"},{"issue":"6","key":"10.1053\/j.seminhematol.2024.03.003_bib0038","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1038\/s41375-020-0714-3","article-title":"CRISPR\/Cas9-generated models uncover therapeutic vulnerabilities of del(11q) CLL cells to dual BCR and PARP inhibition","volume":"34","author":"Quijada-Alamo","year":"2020","journal-title":"Leukemia"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.03.003_bib0039","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000471","article-title":"Performance of anti-CD19 chimeric antigen receptor T cells in genetically defined classes of chronic lymphocytic leukemia","volume":"8","author":"Mancikova","year":"2020","journal-title":"J Immunother Cancer"},{"issue":"2","key":"10.1053\/j.seminhematol.2024.03.003_bib0040","doi-asserted-by":"crossref","first-page":"e304","DOI":"10.1002\/ctm2.304","article-title":"Dissecting the role of TP53 alterations in del(11q) chronic lymphocytic leukemia","volume":"11","author":"Quijada-Alamo","year":"2021","journal-title":"Clin Transl Med"},{"issue":"7","key":"10.1053\/j.seminhematol.2024.03.003_bib0041","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41408-021-00520-5","article-title":"Biological significance of monoallelic and biallelic BIRC3 loss in del(11q) chronic lymphocytic leukemia progression","volume":"11","author":"Quijada-Alamo","year":"2021","journal-title":"Blood Cancer J"},{"issue":"16","key":"10.1053\/j.seminhematol.2024.03.003_bib0042","first-page":"4515","article-title":"Loss-of-function lesions impact B-cell development and fitness but are insufficient to drive CLL in mouse models","volume":"7","author":"Ten Hacken","year":"2022","journal-title":"Blood Adv"},{"issue":"2","key":"10.1053\/j.seminhematol.2024.03.003_bib0043","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1158\/2643-3230.BCD-22-0082","article-title":"In vivo modeling of CLL transformation to Richter syndrome reveals convergent evolutionary paths and therapeutic vulnerabilities","volume":"4","author":"Ten Hacken","year":"2023","journal-title":"Blood Cancer Discov"},{"issue":"11","key":"10.1053\/j.seminhematol.2024.03.003_bib0044","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1084\/jem.20131448","article-title":"Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome","volume":"210","author":"Fabbri","year":"2013","journal-title":"J Exp Med"},{"issue":"10","key":"10.1053\/j.seminhematol.2024.03.003_bib0045","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1073\/pnas.102181599","article-title":"Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression","volume":"99","author":"Bichi","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"10.1053\/j.seminhematol.2024.03.003_bib0046","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1182\/blood.2020008276","article-title":"B-cell receptor signaling and genetic lesions in TP53 and CDKN2A\/CDKN2B cooperate in Richter transformation","volume":"138","author":"Chakraborty","year":"2021","journal-title":"Blood"},{"issue":"22","key":"10.1053\/j.seminhematol.2024.03.003_bib0047","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1182\/blood.2022016272","article-title":"Macrophage- and BCR-derived but not TLR-derived signals support the growth of CLL and Richter syndrome murine models in vivo","volume":"140","author":"Martines","year":"2022","journal-title":"Blood"},{"issue":"5","key":"10.1053\/j.seminhematol.2024.03.003_bib0048","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/sj.leu.2400645","article-title":"Human\/mouse radiation chimera generated from PBMC of B chronic lymphocytic leukemia patients with autoimmune hemolytic anemia produce anti-human red cell antibodies","volume":"11","author":"Marcus","year":"1997","journal-title":"Leukemia"},{"issue":"23","key":"10.1053\/j.seminhematol.2024.03.003_bib0049","first-page":"5968","article-title":"Autologous T cells control B-chronic lymphocytic leukemia tumor progression in human{->}mouse radiation chimera","volume":"59","author":"Shimoni","year":"1999","journal-title":"Cancer Res"},{"issue":"18","key":"10.1053\/j.seminhematol.2024.03.003_bib0050","doi-asserted-by":"crossref","first-page":"8653","DOI":"10.1158\/0008-5472.CAN-07-1198","article-title":"A novel nonobese diabetic\/severe combined immunodeficient xenograft model for chronic lymphocytic leukemia reflects important clinical characteristics of the disease","volume":"67","author":"Durig","year":"2007","journal-title":"Cancer Res"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.03.003_bib0051","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1600-0609.2011.01626.x","article-title":"Investigating the role of CD38 and functionally related molecular risk factors in the CLL NOD\/SCID xenograft model","volume":"87","author":"Aydin","year":"2011","journal-title":"Eur J Haematol"},{"issue":"20","key":"10.1053\/j.seminhematol.2024.03.003_bib0052","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1182\/blood-2010-12-324210","article-title":"A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the disease","volume":"117","author":"Bagnara","year":"2011","journal-title":"Blood"},{"issue":"12","key":"10.1053\/j.seminhematol.2024.03.003_bib0053","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1038\/leu.2013.131","article-title":"Modeling tumor-host interactions of chronic lymphocytic leukemia in xenografted mice to study tumor biology and evaluate targeted therapy","volume":"27","author":"Herman","year":"2013","journal-title":"Leukemia"},{"issue":"13","key":"10.1053\/j.seminhematol.2024.03.003_bib0054","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1182\/blood.2022016934","article-title":"NRX-0492 degrades wild-type and C481 mutant BTK and demonstrates in vivo activity in CLL patient-derived xenografts","volume":"141","author":"Zhang","year":"2023","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.seminhematol.2024.03.003_bib0055","doi-asserted-by":"crossref","first-page":"e86288","DOI":"10.1172\/jci.insight.86288","article-title":"Chronic lymphocytic leukemia cells diversify and differentiate in vivo via a nonclassical Th1-dependent, Bcl-6-deficient process","volume":"1","author":"Patten","year":"2016","journal-title":"JCI Insight"},{"key":"10.1053\/j.seminhematol.2024.03.003_bib0056","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.627020","article-title":"A detailed analysis of parameters supporting the engraftment and growth of chronic lymphocytic leukemia cells in immune-deficient mice","volume":"12","author":"Patten","year":"2021","journal-title":"Front Immunol"},{"issue":"5","key":"10.1053\/j.seminhematol.2024.03.003_bib0057","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/leu.2012.260","article-title":"CD38 signals upregulate expression and functions of matrix metalloproteinase-9 in chronic lymphocytic leukemia cells","volume":"27","author":"Vaisitti","year":"2013","journal-title":"Leukemia"},{"issue":"24","key":"10.1053\/j.seminhematol.2024.03.003_bib0058","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1182\/blood.2020008404","article-title":"ROR1 targeting with the antibody drug- conjugate VLS-101 is effective in Richter syndrome patient-derived xenograft mouse models","volume":"137","author":"Vaisitti","year":"2021","journal-title":"Blood"},{"issue":"Supplement 1","key":"10.1053\/j.seminhematol.2024.03.003_bib0059","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1182\/blood-2022-160380","article-title":"Decreased apoptotic priming and loss of Bcl-2 dependence are functional hallmarks of Richter's syndrome","volume":"140","author":"Rigo","year":"2022","journal-title":"Blood"},{"issue":"13","key":"10.1053\/j.seminhematol.2024.03.003_bib0060","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1182\/blood.2022016211","article-title":"Anti-CD37 \u03b1-amanitin-conjugated antibodies as potential therapeutic weapons for Richter syndrome","volume":"140","author":"Vaisitti","year":"2022","journal-title":"Blood"},{"issue":"9","key":"10.1053\/j.seminhematol.2024.03.003_bib0061","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1038\/leu.2016.382","article-title":"Duvelisib treatment is associated with altered expression of apoptotic regulators that helps in sensitization of chronic lymphocytic leukemia cells to venetoclax (ABT-199)","volume":"31","author":"Patel","year":"2017","journal-title":"Leukemia"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.03.003_bib0062","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41375-023-02095-5","article-title":"Chronic lymphocytic leukemia patient-derived xenografts recapitulate clonal evolution to Richter transformation","volume":"38","author":"Playa-Albinyana","year":"2024","journal-title":"Leukemia"},{"issue":"11","key":"10.1053\/j.seminhematol.2024.03.003_bib0063","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.3390\/cancers15112989","article-title":"Modeling the tumor microenvironment and cancer immunotherapy in next-generation humanized mice","volume":"15","author":"Chen","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1053\/j.seminhematol.2024.03.003_bib0064","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nbt.2858","article-title":"Development and function of human innate immune cells in a humanized mouse model","volume":"32","author":"Rongvaux","year":"2014","journal-title":"Nat Biotechnol"},{"issue":"10","key":"10.1053\/j.seminhematol.2024.03.003_bib0065","doi-asserted-by":"crossref","first-page":"e10576","DOI":"10.15252\/emmm.201910576","article-title":"The IL-6 signaling complex is a critical driver, negative prognostic factor, and therapeutic target in diffuse large B-cell lymphoma","volume":"11","author":"Hashwah","year":"2019","journal-title":"EMBO Mol Med"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.03.003_bib0066","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/0300985820970144","article-title":"Development of mast cell and eosinophil hyperplasia and HLH\/MAS-like disease in NSG-SGM3 mice receiving human CD34+ hematopoietic stem cells or patient-derived leukemia xenografts","volume":"58","author":"Janke","year":"2021","journal-title":"Vet Pathol"},{"key":"10.1053\/j.seminhematol.2024.03.003_bib0067","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.642466","article-title":"PD-1 inhibition enhances blinatumomab response in a UCB\/PDX model of relapsed pediatric B-cell acute lymphoblastic leukemia","volume":"11","author":"Wunderlich","year":"2021","journal-title":"Front Oncol"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196324000568?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196324000568?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T09:19:27Z","timestamp":1720516767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196324000568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":67,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0037196324000568"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2024.03.003","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mouse models of CLL: In vivo modeling of disease initiation, progression, and transformation","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2024.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}